Our results in the liver also confirmed that BCL2L11 expression was significantly downregulated, while NAGS, HDHD3 and RMND1 expression levels were significantly upregulated in NAFLD. The gene discussed is HDHD3; the disease is metabolic dysfunction-associated steatotic liver disease.